Viral receptors and vector purification: New approaches for generating clinical-grade reagents

被引：47
|
作者：
Summerford, C
Samulski, RJ
机构：
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
来源：
NATURE MEDICINE | 1999年 / 5卷 / 05期
关键词：
D O I：
10.1038/8470
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：587 / 588
页数：2
相关论文
共 50 条
  • [21] A new standardized clinical-grade protocol for banking human umbilical cord tissue cells
    Fazzina, Raffaella
    Mariotti, Andrea
    Procoli, Annabella
    Fioravanti, Daniela
    Iudicone, Paola
    Scambia, Giovanni
    Pierelli, Luca
    Bonanno, Giuseppina
    TRANSFUSION, 2015, 55 (12) : 2864 - 2873
  • [22] Expanding the Understanding of Biases in Development of Clinical-Grade Molecular Signatures: A Case Study in Acute Respiratory Viral Infections
    Lytkin, Nikita I.
    McVoy, Lauren
    Weitkamp, Joern-Hendrik
    Aliferis, Constantin F.
    Statnikov, Alexander
    PLOS ONE, 2011, 6 (06):
  • [23] 10-Year stability of clinical-grade serum-free γ-retroviral vector-containing medium
    Herbst, F.
    Ball, C. R.
    Zavidij, O.
    Fessler, S.
    Schmidt, M.
    Veelken, H.
    von Kalle, C.
    Glimm, H.
    GENE THERAPY, 2011, 18 (02) : 210 - 212
  • [24] A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell line
    Patricio, Maria I.
    Barnard, Alun R.
    Green, Alexander L.
    During, Matthew J.
    Sen, Arjune
    MacLaren, Robert E.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 55 : 25 - 29
  • [25] A clinical-grade adenoviral-vector encoding MMP-8 as tool to reverse hepatic fibrosis.
    Armendariz-Borunda, J
    Siller, F
    Salgado, S
    Garcia-Banuelos, J
    Vera, J
    Miranda, A
    Grijalva, G
    Segura, J
    Aguilar-Cordova, E
    HEPATOLOGY, 2000, 32 (04) : 178A - 178A
  • [26] 10-Year stability of clinical-grade serum-free γ-retroviral vector-containing medium
    F Herbst
    C R Ball
    O Zavidij
    S Fessler
    M Schmidt
    H Veelken
    C von Kalle
    H Glimm
    Gene Therapy, 2011, 18 : 210 - 212
  • [27] Validation of viable producer cell removal/inactivation from clinical-grade oncoretroviral vector supernatant produced in cell factories
    Przybylowski, M
    Hakakha, A
    Fan, Y
    Riviere, I
    MOLECULAR THERAPY, 2004, 9 : S32 - S32
  • [28] Efficiency, quality and traceability of PEIpro transfection reagent for clinical grade viral vector manufacturing
    Hellal, Malik
    Porte, Mathieu
    Stock, Fabrice
    Philipson, Yann
    Kedinger, Valerie
    Warteil-Weill, Claire
    Belguise, Pascale
    Erbacher, Patrick
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [29] A new clinical-grade MEMS-based cell sorter for adoptive T-cell therapy
    Yee, Cassian
    Farrar, Erik
    Grummitt, Daryl
    Harley, John
    Linton, Jim
    Foster, John
    CANCER RESEARCH, 2012, 72
  • [30] Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in Cell Factories
    Przybylowski, M
    Hakakha, A
    Stefanski, J
    Hodges, J
    Sadelain, M
    Rivière, I
    GENE THERAPY, 2006, 13 (01) : 95 - 100
12345